Skip to main content
37°
Rain Shower
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Avita Medical, Inc. - Common Stock
(NQ:
RCEL
)
8.620
-0.010 (-0.12%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 11, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Avita Medical, Inc. - Common Stock
< Previous
1
2
3
Next >
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025
April 09, 2025
Sixteen abstracts to present real-world findings and clinical innovations across AVITA Medical’s expanded portfolio, including RECELL, Cohealyx, and PermeaDerm
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity
April 03, 2025
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific
March 17, 2025
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical to Present at TD Cowen’s 45ᵗʰ Annual Health Care Conference
February 26, 2025
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
February 14, 2025
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results
February 13, 2025
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance
January 07, 2025
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds
December 23, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
December 19, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 18, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
November 25, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
November 12, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
November 08, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Reports Third Quarter Financial Results
November 07, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical to Announce Third Quarter 2024 Financial Results
October 10, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference
September 12, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference
September 10, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
August 08, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Reports Second Quarter Financial Results
August 08, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
August 01, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care
July 31, 2024
Exclusive development and distribution agreement with Regenity Biosciences provides AVITA Medical with the commercialization rights to a unique collagen-based dermal matrix following 510(k) clearance
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical to Announce Second Quarter 2024 Financial Results
July 11, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
July 01, 2024
Donna Shiroma retires after distinguished service as General Counsel
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Achieves Milestone with First Case Using RECELL GO
June 05, 2024
Joseph M. Still Burn Center at Doctors Hospital of Augusta first to treat a patient using AVITA Medical’s FDA-Approved RECELL GO System for thermal burn wounds and full-thickness skin defects
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Announces FDA Approval of RECELL GO
May 30, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
May 16, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Reports First Quarter Financial Results
May 13, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical to Announce First Quarter 2024 Financial Results
April 15, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Updates Expected First Quarter 2024 Revenue
April 10, 2024
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement
February 29, 2024
From
AVITA Medical
Via
GlobeNewswire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
